J. Rossouw, G. Anderson, and R. Prentice, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, JAMA, vol.288, issue.3, pp.321-333, 2002.

V. Beral, Breast cancer and hormone-replacement therapy: the Million Women Study, The Lancet, vol.362, issue.9392, pp.419-427, 2003.
DOI : 10.1016/S0140-6736(03)14596-5

C. Clarke, S. Glaser, and C. Uratsu, Recent Declines in Hormone Therapy Utilization and Breast Cancer Incidence: Clinical and Population-Based Evidence, Journal of Clinical Oncology, vol.24, issue.33, pp.49-50, 2006.
DOI : 10.1200/JCO.2006.08.6504

A. Glass, J. Lacey, J. Carreon, and J. , Breast Cancer Incidence, 1980 2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status, JNCI Journal of the National Cancer Institute, vol.99, issue.15, pp.1152-1161, 1980.
DOI : 10.1093/jnci/djm059

A. Jemal, E. Ward, and M. Thun, Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women, Breast Cancer Research, vol.292, issue.1 Suppl, p.28, 2007.
DOI : 10.1001/jama.292.16.1983

K. Kerlikowske, D. Miglioretti, and D. Buist, Declines in Invasive Breast Cancer and Use of Postmenopausal Hormone Therapy in a Screening Mammography Population, JNCI Journal of the National Cancer Institute, vol.99, issue.17, pp.1335-1339, 2007.
DOI : 10.1093/jnci/djm111